An early diagnosis does more than guide one child's care. Each new diagnosis also helps researchers understand a condition better—and makes new treatments more likely for every family living with it.
Ben Wilson's fatherly intuition led to his son's ultra-rare diagnosis. After a year of being told nothing was wrong, whole exome sequencing gave the Wilsons an answer—and a way to get ahead of what comes next.
Florida's 2025 childhood-health laws are a meaningful start—but newborns and student athletes aren't the only kids who benefit from genetic insight. The case for making pediatric genetic screening available to every child as preventive medicine.
Our new white paper, now available in AHIP's resource library, lays out the case that identifying genetic risk early—well before age 5—can improve children's health outcomes while lowering long-term costs for health plans.
Read on ahip.org ↗
A new JAMA viewpoint argues that rare genetic diseases are a core health system problem, not a niche concern. Here's what the research says — and how GeneSprout is helping families, providers, and health plans act on it.
